PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
10-Mar-2020 Paradigm Shift in Angiography: Kinepict Medical Imaging Technology (KMIT) Receives US FDA 510(K) Clearance Kinepict Health Ltd.
10-Mar-2020 Freeline receives Orphan Drug Designation from the European Commission for FLT190 for the treatment of Fabry Disease Freeline
10-Mar-2020 PureTech Affiliate Gelesis Named One of the World’s Most Innovative Companies for 2020 by Fast Company PureTech
10-Mar-2020 Orgenesis Year-End Results, outlines business model and POCare strategy post-Masthercell sale Orgenesis
10-Mar-2020 Pivotal Acquires Akcelis, an Industry Leader in Patient Engagement, Recruitment and Retention Pivotal
10-Mar-2020 Positive results from Phase IIb field study of FLU-v vaccine (FLU-v 003), which has been developed by Imutex Limited, hVIVO's 49% joint venture with the SEEK Group. FLU-v is a first-in-class ‘universal’, broad spectrum, standalone, influenza vaccine candidate and the results have now been published in a peer review journal Open Orphan plc
10-Mar-2020 New initiative to give cancer patients easier access to clinical trials and increase patient diversity in research The Christie NHS Foundation Trust and Innovative Trials
09-Mar-2020 Chemotherapy after surgery halves risk of rare kidney cancer coming back The Institute of Cancer Research
09-Mar-2020 Nanoform and Orion collaborate on next-generation drug development Nanoform
09-Mar-2020 Kancera provides an update on the development of the drug candidate KAND145 Kancera AB
09-Mar-2020 Hansa Biopharma announces long term follow-up data that demonstrates 2-year graft survival of 89% after imlifdase treatment and transplantation Hansa Biopharma AB
09-Mar-2020 Marinomed extends the range of Marinosolv® applications Marinomed Biotech AG
09-Mar-2020 SHIONOGI ANNOUNCES LAUNCH OF MULPLEO® (LUSUTROMBOPAG) IN THE UK, FOR THE TREATMENT OF SEVERE THROMBOCYTOPENIA IN ADULT PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING INVASIVE PROCEDURES Shionogi & Co., Ltd
06-Mar-2020 Orexo submits application for vorvida® to the FDA to enable commercialization in the US Orexo AB
06-Mar-2020 Biotalys announces second closing of €45 million Series C financing round Biotalys
06-Mar-2020 vTv Therapeutics has potential to be strong player in up-and-coming oral drug market for type 1 diabetics, says GlobalData vTv Therapeutics
06-Mar-2020 Abbott Aims to Optimize TAVI Implants with European Approval of FlexNav™ Delivery System for the Company's Portico™ Valve Abbott
06-Mar-2020 New approach for immediate pain free diagnosis of oral cancers Zilico Ltd
06-Mar-2020 Biotalys announces second closing of €45 million Series C financing round Biotalys
06-Mar-2020 NuCana Receives Positive Opinion for Orphan Drug Designation in the European Union for Acelarin (NUC-1031) for the Treatment of Patients with Biliary Tract Cancer NuCana plc